APA

Xu Q., Xu Y., Pan B., Wu L., Ren X., Zhou Y., Mao F., Lin Y., Guan J., Shen S., Zhang X., Wang C., Zhong Y., Zhou L., Liang Z., Zhao H. & Sun Q. (20180212). TTK is a favorable prognostic biomarker for triple-negative breast cancer survival. : Oncotarget.

Chicago

Xu Qianqian, Xu Yali, Pan Bo, Wu Liangcai, Ren Xinyu, Zhou Yidong, Mao Feng, Lin Yan, Guan Jinghong, Shen Songjie, Zhang Xiaohui, Wang Changjun, Zhong Ying, Zhou Liangrui, Liang Zhiyong, Zhao Haitao and Sun Qiang. 20180212. TTK is a favorable prognostic biomarker for triple-negative breast cancer survival. : Oncotarget.

Harvard

Xu Q., Xu Y., Pan B., Wu L., Ren X., Zhou Y., Mao F., Lin Y., Guan J., Shen S., Zhang X., Wang C., Zhong Y., Zhou L., Liang Z., Zhao H. and Sun Q. (20180212). TTK is a favorable prognostic biomarker for triple-negative breast cancer survival. : Oncotarget.

MLA

Xu Qianqian, Xu Yali, Pan Bo, Wu Liangcai, Ren Xinyu, Zhou Yidong, Mao Feng, Lin Yan, Guan Jinghong, Shen Songjie, Zhang Xiaohui, Wang Changjun, Zhong Ying, Zhou Liangrui, Liang Zhiyong, Zhao Haitao and Sun Qiang. TTK is a favorable prognostic biomarker for triple-negative breast cancer survival. : Oncotarget. 20180212.